71 research outputs found
Habitatvalg og beitestrategi hos overvintrende fjæreplytt (Calidris maritima)
Fjæreplytt (Calidris maritima) er verdens nordligste overvintrende vader og oppholder seg gruppevis i fjæresonen i Tromsøområdet gjennom vinteren. En flokk fjæreplytt ble observert å konsekvent bytte beitehabitat mellom dag og natt. Ved hjelp av radiosendere og individuelle ringmerker ble natthabitat avdekket og flokken verifisert som den samme i begge habitat. For å undersøke hva som kunne styre fuglenes valg av habitat ble mattilgang og predatoraktivitet vurdert.
Næringsprøver ble samplet fra begge habitatat og potensielle byttedyr registrert for å få et bilde av næringstilgangen. Tidsbudsjett ble tatt på beitende fugl i dag- og natthabitat for å finne forskjell i beiteintensitet. I henseende å vurdere predatoraktivitet ble det tatt tidsbudsjetter på anti-predator atferd og gått sportransekt i begge habitat.
Næringstilgangen ble ikke funnet å være forskjellig med hensyn på antall byttedyr. Det var kun forskjellig fordeling av type byttedyr, med flest blåskjell (Mytilus edulis) i daghabitatet og flest strandsnegl (Littorina spp.) i natthabitatet. Beiteintensiteten var høyere i natthabitatet med 83 % kontra 68 % i daghabitatet. Fuglene viste 66 % anti-predator atferd i form av flukt i daghabitatet og 40 % i natthabitatet og sportransektene ga indikasjon på større aktivitet av nattaktive predatorer som katt og mink i daghabitatet. Disse resultatene foreslår at fjæreplyttene avveier mattilgang og predatorpress når de velger beitehabitat.
Predatoraktiviteten i daghabitatet kan indirekte skyldes menneskelig aktivitet som således påvirker et viktig beiteområde for den lokale bestanden av fjæreplytt i Tromsøområdet.
Emneord: fjæreplytt, Calidris maritima, habitatvalg, predatorpress, avveing, anti-predator atferd, beiting, fjæreson
Gytefeltskartlegging Nordøstarktisk hyse: Toktnummer 2022609
Gytekartleggingstokt for nordøstarktisk hyse ble gjennomført 8. -19. april 2022 med FF Kristine Bonnevie. Toktet startet i Bodø og ble avsluttet i Tromsø. Toktet dekket det antatte gyteområdet langs Eggakanten mellom Malangsgrunnen og Bjørnøyrenna. Kontinuerlige akustiske registringer ble gjort langs 3194 nautiske mil kurslinjer. Det ble tatt 38 stasjoner med egghåv og CTD, og 29 bunntrål. Gytende hyse ble funnet i de fleste trålhalene. De innsamlete eggene er sendt til genetisk analyse for å kunne skille torsk- og hyseegg.publishedVersio
Genome-wide risk prediction of common diseases across ancestries in one million people
Peer reviewe
Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools
Migraine is three times more prevalent in people with bipolar disorder or depression. The relationship between
schizophrenia and migraine is less certain although glutamatergic and serotonergic neurotransmission are implicated in both. A shared genetic basis to migraine and mental disorders has been suggested but previous studies
have reported weak or non-significant genetic correlations and five shared risk loci. Using the largest samples to
date and novel statistical tools, we aimed to determine the extent to which migraine’s polygenic architecture
overlaps with bipolar disorder, depression and schizophrenia beyond genetic correlation, and to identify shared
genetic loci.
Summary statistics from genome-wide association studies were acquired from large-scale consortia for migraine
(n cases = 59 674; n controls = 316 078), bipolar disorder (n cases = 20 352; n controls = 31 358), depression
(n cases = 170 756; n controls = 328 443) and schizophrenia (n cases = 40 675, n controls = 64 643). We applied the bivariate causal mixture model to estimate the number of disorder-influencing variants shared between migraine
and each mental disorder, and the conditional/conjunctional false discovery rate method to identify shared loci.
Loci were functionally characterized to provide biological insights.
Univariate MiXeR analysis revealed that migraine was substantially less polygenic (2.8 K disorder-influencing variants) compared to mental disorders (8100–12 300 disorder-influencing variants). Bivariate analysis estimated that
800 (SD = 300), 2100 (SD = 100) and 2300 (SD = 300) variants were shared between bipolar disorder, depression and
schizophrenia, respectively. There was also extensive overlap with intelligence (1800, SD = 300) and educational attainment (2100, SD = 300) but not height (1000, SD = 100). We next identified 14 loci jointly associated with migraine
and depression and 36 loci jointly associated with migraine and schizophrenia, with evidence of consistent genetic
effects in independent samples. No loci were associated with migraine and bipolar disorder. Functional annotation
mapped 37 and 298 genes to migraine and each of depression and schizophrenia, respectively, including several
novel putative migraine genes such as L3MBTL2, CACNB2 and SLC9B1. Gene-set analysis identified several putative
gene sets enriched with mapped genes including transmembrane transport in migraine and schizophrenia.
Most migraine-influencing variants were predicted to influence depression and schizophrenia, although a minority
of mental disorder-influencing variants were shared with migraine due to the difference in polygenicity. Similar
overlap with other brain-related phenotypes suggests this represents a pool of ‘pleiotropic’ variants that influence
vulnerability to diverse brain-related disorders and traits. We also identified specific loci shared between migraine and each of depression and schizophrenia, implicating shared molecular mechanisms and highlighting candidate
migraine genes for experimental validation
Recommended from our members
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.
Tobacco and alcohol use are leading causes of mortality that influence risk for many complex diseases and disorders1. They are heritable2,3 and etiologically related4,5 behaviors that have been resistant to gene discovery efforts6-11. In sample sizes up to 1.2 million individuals, we discovered 566 genetic variants in 406 loci associated with multiple stages of tobacco use (initiation, cessation, and heaviness) as well as alcohol use, with 150 loci evidencing pleiotropic association. Smoking phenotypes were positively genetically correlated with many health conditions, whereas alcohol use was negatively correlated with these conditions, such that increased genetic risk for alcohol use is associated with lower disease risk. We report evidence for the involvement of many systems in tobacco and alcohol use, including genes involved in nicotinic, dopaminergic, and glutamatergic neurotransmission. The results provide a solid starting point to evaluate the effects of these loci in model organisms and more precise substance use measures
Loss-of-Function Genomic Variants Highlight Potential Therapeutic Targets for Cardiovascular Disease
Pharmaceutical drugs targeting dyslipidemia and cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic disorders. To identify potential novel CVD drug targets without these adverse effects, we perform genome-wide analyses of participants in the HUNT Study in Norway (n = 69,479) to search for protein-altering variants with beneficial impact on quantitative blood traits related to cardiovascular disease, but without detrimental impact on liver function. We identify 76 (11 previously unreported) presumed causal protein-altering variants associated with one or more CVD- or liver-related blood traits. Nine of the variants are predicted to result in loss-of-function of the protein. This includes ZNF529:p.K405X, which is associated with decreased low-density-lipoprotein (LDL) cholesterol (P = 1.3 × 10−8) without being associated with liver enzymes or non-fasting blood glucose. Silencing of ZNF529 in human hepatoma cells results in upregulation of LDL receptor and increased LDL uptake in the cells. This suggests that inhibition of ZNF529 or its gene product should be prioritized as a novel candidate drug target for treating dyslipidemia and associated CVD
A SUMO-regulated activation function controls synergy of c-Myb through a repressor–activator switch leading to differential p300 recruitment
Synergy between transcription factors operating together on complex promoters is a key aspect of gene activation. The ability of specific factors to synergize is restricted by sumoylation (synergy control, SC). Focusing on the haematopoietic transcription factor c-Myb, we found evidence for a strong SC linked to SUMO-conjugation in its negative regulatory domain (NRD), while AMV v-Myb has escaped this control. Mechanistic studies revealed a SUMO-dependent switch in the function of NRD. When NRD is sumoylated, the activity of c-Myb is reduced. When sumoylation is abolished, NRD switches into being activating, providing the factor with a second activation function (AF). Thus, c-Myb harbours two AFs, one that is constitutively active and one in the NRD being SUMO-regulated (SRAF). This double AF augments c-Myb synergy at compound natural promoters. A similar SUMO-dependent switch was observed in the regulatory domains of Sp3 and p53. We show that the change in synergy behaviour correlates with a SUMO-dependent differential recruitment of p300 and a corresponding local change in histone H3 and H4 acetylation. We therefore propose a general model for SUMO-mediated SC, where SUMO controls synergy by determining the number and strength of AFs associated with a promoter leading to differential chromatin signatures
GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer
Correction: Volume12, Issue1 Article Number7354 DOI10.1038/s41467-021-27675-w PublishedDEC 16 2021Thyroid stimulating hormone (TSH) is critical for normal development and metabolism. To better understand the genetic contribution to TSH levels, we conduct a GWAS meta-analysis at 22.4 million genetic markers in up to 119,715 individuals and identify 74 genome-wide significant loci for TSH, of which 28 are previously unreported. Functional experiments show that the thyroglobulin protein-altering variants P118L and G67S impact thyroglobulin secretion. Phenome-wide association analysis in the UK Biobank demonstrates the pleiotropic effects of TSH-associated variants and a polygenic score for higher TSH levels is associated with a reduced risk of thyroid cancer in the UK Biobank and three other independent studies. Two-sample Mendelian randomization using TSH index variants as instrumental variables suggests a protective effect of higher TSH levels (indicating lower thyroid function) on risk of thyroid cancer and goiter. Our findings highlight the pleiotropic effects of TSH-associated variants on thyroid function and growth of malignant and benign thyroid tumors. Thyroid stimulating hormone (TSH) is critical for normal development and metabolism. Here, the authors conduct a GWAS and suggest protective effect of higher TSH on risk of thyroid cancer and goitre.Peer reviewe
Author Correction:GWAS of thyroid stimulating hormone highlights the pleiotropic effects and inverse association with thyroid cancer
The original version of this article contained an error in the results, in the second paragraph of the subsection entitled “Fine-mapping for potentially causal variants among TSH loci”, in which effect sizes for two variants were incorrectly reported
Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations
Osteoarthritis affects over 300 million people worldwide. Here, we conduct a genome-wide association study meta-analysis across 826,690 individuals (177,517 with osteoarthritis) and identify 100 independently associated risk variants across 11 osteoarthritis phenotypes, 52 of which have not been associated with the disease before. We report thumb and spine osteoarthritis risk variants and identify differences in genetic effects between weight-bearing and non-weight-bearing joints. We identify sex-specific and early age-at-onset osteoarthritis risk loci. We integrate functional genomics data from primary patient tissues (including articular cartilage, subchondral bone, and osteophytic cartilage) and identify high-confidence effector genes. We provide evidence for genetic correlation with phenotypes related to pain, the main disease symptom, and identify likely causal genes linked to neuronal processes. Our results provide insights into key molecular players in disease processes and highlight attractive drug targets to accelerate translation
- …